Experimental models of multiple sclerosis

Revue Neurologique

Volumn 163, Issue 6-7, 2007, Pages 651-655

  Lassmann, H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University of Vienna   (Austria)

Author keywords

Autoimmune encephalomyelitis; Axonal injury; Demyelination; Inflammation; Multiple sclerosis

Indexed keywords

AUTOIMMUNITY; AXONAL INJURY; CLINICAL FEATURE; CONFERENCE PAPER; DEMYELINATING DISEASE; DISEASE MODEL; ENCEPHALOMYELITIS; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN;

EID: 34347333268     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)90474-9     Document Type: Conference Paper

References (40)

1. ABOUL-ENEIN F, WEISER P, HÖ FTBERGER R, LASSMANN H, B RADL M. (2006). Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol (Berl), 111: 539-547.
2. ABOUL-ENEIN F, RAUSCHKA H, KORNEL B et al. (2003). Preferential loss of myelin associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropath Exp Neurol, 62: 25-33.
3. ALOISI F, PUJOL-BORRELL R. (2006). Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol, 6: 205-217.
4. BABBE H, ROERS A, WAISMAN A et al. (2000). Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med, 192: 393-404.
5. BEN-NUN A, WEKERLE H, COHEN IR. (1981). The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol, 11: 195-199.
6. BERGER T, WEERTH S, KOJIMA K, LININGTON C, WEKERLE H, LASSMANN H. (1997). Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest, 76: 355-364.
7. BOOSS J, ESIRI MM, TOURTELLOTTE WW, MASON DY. (1983). Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci, 62: 219-232.
8. BRINK BP, VEERHUIS R, BREIJ EC, VAN DER VALK P, DIJKSTRA CD, BO L. (2005). The pathology of multiple sclerosis is location dependent: no significant complement activation is detected in purely cortical lesions. J Neuropath Exp Neurol, 64: 147-155.
9. CABARROCAS J, BAUER J, PIAGGIO E, LIBLAU R, LASSMANN H. (2003). Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. European Journal of Immunology, 33: 1174-1182.
10. FELTS PA, WOOLSTON AM, FERNANDO HB et al. (2005). Inflammation and primary demyelination induced by the intraspinal injections of lipopolysaccharide. Brain, 128: 1649-1666.
11. FERGUSON B, MATYSZAK MK, ESIRI MM, PERRY VH. (1997). Axonal damage in acute multiple sclerosis lesions. Brain, 120: 393-399.
12. FLUGEL A, BERKOWICZ T, RITTER T et al. (2001). Migratory activity and functional changes of green fluorescent effector cells before and during experiemntal autoimmune encephalomyelitis. Immunity, 14: 547-560.
13. FRIESE MA, FUGGER L. (2005). Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain, 128: 1747-1763.
14. GAY FW, DRYE GW, DICK GWA, ESIRI MM. (1997). The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: Identification and characterization of the primary demyelinating lesion. Brain, 120: 1461-1483.
15. GIESS R, MAURER M, LINKER R et al. (2002). Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch-Neurol, 59: 407-409.
16. GOLD R, LININGTON C, LASSMANN H. (2006). Understanding pathogenesis and therapy of multiple sclerosis vial animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 129: 1953-1971.
17. HOCHMEISTER S, GRUNDTNER R, BAUER J et al. (2006). Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropath Exp Neurol, 65: 855-865.
18. HÖFTBERGER R, ABOUL-ENEIN F, BRUECK W et al. (2004). Expression of Major Histocompatibiltiy Complex Class I Molecules on the different Cell Types in Multiple Sclerosis lesions. Brain Pathol, 14: 43-50.
19. HOHLFELD R, WEKERLE H. (2004). Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci (USA), 101(Suppl 2): 14599-14606
20. HUSEBY ES, LIGGITT D, BRABB T, SCHNABEL B, OHLEN C, GOVERMAN J. (2001). A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. Journal of Experimental Medicine, 194: 669-676.
21. KERLERO DE ROSBO N, MENDEL I, BEN NUN A. (1995). Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG) derrived peptide: preliminary analysis of MOG T-cell epitopes. Eur J Immunol, 25: 985-993.
22. KUTZELNIGG A, LUCCHINETTI CF, STADELMANN C et al. (2005). Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain, 128: 2705-2712.
23. LASSMANN H. (1983). Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer Schriftenr. Neurol, 25: 1-135.
24. LININGTON C, BRADL M, LASSMANN H, BRUNNER C, VASS K. (1988). Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Amer J Pathol, 130: 443-454
25. LINKER RA, MAURER M, GAUPP S et al. (2002). CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat-Med, 8: 620-624.
26. LOUIS JC, MAGAL E, TAKAYAMA S, VARON S. (1993). CNTF protection of oligodendrocytes against natura and tumor necrosis factor-induced death. Science, 259: 689-692.
27. LUCCHINETTI C, BRÜCK W, PARISI J, SCHEITHAUER, B, RODRIGUEZ M, LASSMANN, H. (2000). Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol, 47: 707-717.
28. MARBURG O. (1906). Die sogenannte "akute Multiple Sklerose" Jahrb. Psychiatrie, 27: 211-312.
29. MEDANA I, MARTINIC MA, WEKERLE H, NEUMANN H. (2001). Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol, 159: 809-815.
30. MERKLER D, ERNSTING T, KERSCHENSTEINER M, BRÜCK W, STADELMANN C. (2006). A new focal EAE model of cortical demyelination: MS-like lesions with rapid resolution of inflammation and extensive remyelination. Brain, 129: 1972-1983
31. NEUMANN H, MEDANA I, BAUER J, LASSMANN H. (2002). Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trend Neurosci, 25: 313-319.
32. NOSEWORTHY JH, LUCCHINETTI C, RODRIGUEZ M, WEINSHENKER B. (2000). Multiple sclerosis. N Engl J Med, 343: 938-952.
33. PETERSON JW, BO L, MORK S, CHANG A, TRAPP BD. (2001). Transsected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol, 50: 389-400.
34. POMEROY IM, MATTHEWS PM, FRANK JA, JORDAN EK, ESIRI MM. (2005). Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain, 128: 2713-2721.
35. SERAFINI B, ROSICARELLI B, MAGLIOZZI R, STIGLIANO E, ALOISI F. (2004). Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol, 14: 164-174.
36. STADELMANN C, LUDWIN S, TABIRA T et al. (2005). Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 128: 979-987
37. STORCH MK, BAUER J, LININGTON C, OLSSON T, WEISSERT R, LASSMANN H. (2006). Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related. J Neuropathol Exp Neurol, 65: 1137-1142.
38. STORCH MK, STEFFERL A, BREHM U et al. (1998b). Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol, 8: 681-694.
39. + T cells are encephalitogenic and produce severe disease in C57Bl/6 mice. J Immunol, 166: 7579-7587.
40. TRAPP BD, PETERSON J, RANSOHOFF RM et al. (1998). Axonal transection in the lesions of multiple sclerosis. N-Engl-J-Med, 338: 278-285.